COMP <GO>
NATR vs UNH // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Nature's Sunshine Products Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: NATR 8
— UNH 5
■ METRIC PARITY
LAST: $12.25 (-0.24%) • MKT CAP: $216.1M
options-implied-move
—
LAST: $406.97 (-0.96%) • MKT CAP: $368.83B
options-implied-move
6.74%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NATR VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NATR | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 72.40% | 88.57% | -16.17 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 28.90% | 11.47% | +17.43 | NATR | /roic <GO> |
| EV/EBITDA & P/E Valuation | 4.0x | 16.4x | -12.45 | NATR | /valuation <GO> |
| Free Cash Flow Yield | 13.35% | 6.48% | +6.87 | NATR | /fcf-yield <GO> |
| Operating Margin | 5.20% | 4.82% | +0.38 | NATR | /operating-margins <GO> |
| Net Profit Margin | 4.10% | 3.14% | +0.96 | NATR | /net-margins <GO> |
| Revenue Growth (YoY) | 5.70% | 6.46% | -0.76 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.33 | 3.12 | +1.21 | NATR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | NATR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.8 | 59.2 | -17.44 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 10.3x | 17.7x | -7.44 | NATR | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $216.1M | $368.83B | -$368.61B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NATR REV | UNH REV | NATR GROSS % | UNH GROSS % | NATR FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $480.1M | $447.57B | 72.4% | 88.7% | $28.8M | $16.07B |
| FY 2024 | $454.4M | $400.28B | 71.5% | 88.3% | $14.3M | $20.70B |
| FY 2023 | $445.3M | $371.62B | — | 89.6% | $41.2M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NATR // BETA —
UNH // BETA 0.33